MRI-Guided radiation tailors treatment to each Patient's risk
NCT ID NCT06050707
Summary
This study is testing a personalized approach to radiation therapy for anal cancer. Doctors will use MRI scans during treatment to guide radiation and adjust the dose based on each patient's specific risk level. The goal is to better control the cancer while trying to reduce side effects and improve quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Allegheny Health Network
NOT_YET_RECRUITINGPittsburgh, Pennsylvania, 15212, United States
Contact
-
Austin Health
NOT_YET_RECRUITINGHeidelberg, Victoria, 3084, Australia
Contact
-
Medical College of Wisconsin Cancer Center
NOT_YET_RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2C1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.